The Cambridge Healthtech Institute (CHI) continued its annual Discovery on Target series of conferences as a virtual platform due to the COVID-19 pandemic preventing live attendance at large events This, the 18th annual conference, continued the multitrack format, providing coverage of a wide range of targeting topics, including RNA, PROTACs, antibodies, proteins, immunology and oncology, nonalcoholic steatohepatitis, fibrosis, models, cell/gene therapy, kinase inhibitor and GPCR-based drug discovery, biomarkers Along with live and on-demand presentations, all with potential for Q&A to continue discussion and collaborations, there were posters, short courses, plenary sessions and panel discussions;a virtual exhibit hall was also created This report will cover some of the presentations given relating to drug discovery and potential targets
CHI’s 18th annual discovery on target